OpenVSafe by OpenVAERS
Search V-safe

38J-25676-65896

2 vaccinations 1 coded response 16 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
36-40
ZIP prefix
276 / NC
Registered
2021-12-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-02
    Dose 1 — Janssen/Johnson & Johnson
  2. 2021-12-19
    Registered in v-safe
  3. 2021-12-19
    Dose 2 — Janssen/Johnson & Johnson
  4. 2021-12-19
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  5. 2021-12-20
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness
    Adult check-in
  6. 2021-12-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Joint pains, Muscle or body aches
    Adult check-in
  7. 2021-12-22
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache · Be unable to do your normal daily activities
    Adult check-in
  8. 2021-12-23
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Muscle or body aches
    Adult check-in
  9. 2021-12-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-12-25
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-12-27
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2022-01-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  13. 2022-01-09
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  14. 2022-01-16
    Survey response — day 28, dose 2
    MedDRA: COVID-19, Cough, Fatigue, Headache, Nasal congestion, Oropharyngeal pain, Quarantine, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Covid +, mild sore throat, mild non-productive cough, moderate fatigue, mild runny nose, mild nasal congestion, mild headache, NO fever, currently in quarantine
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-01-23
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  16. 2022-01-30
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  17. 2022-03-20
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  18. 2022-06-19
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  19. 2022-12-22
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-02Janssen/Johnson & Johnson No
22021-12-19Janssen/Johnson & Johnson No

Free text

Release 10 — day 28, dose 2

2022-01-16

Symptoms: Covid +, mild sore throat, mild non-productive cough, moderate fatigue, mild runny nose, mild nasal congestion, mild headache, NO fever, currently in quarantine

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDCOVID-19 · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDNasal congestion · · ✓
SDOropharyngeal pain · · ✓
SDQuarantine · · ✓
SDRhinorrhoea · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release